{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:49:53Z","timestamp":1793407793835,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"am","delay-in-days":285,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["2U54GM104942"],"award-info":[{"award-number":["2U54GM104942"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["R21DA040187"],"award-info":[{"award-number":["R21DA040187"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["1UG3DA044825"],"award-info":[{"award-number":["1UG3DA044825"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.josat.2023.209252","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T23:06:50Z","timestamp":1701990410000},"page":"209252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Quantifying a potential protective effect of buprenorphine on fatality risk during acute fentanyl exposures"],"prefix":"10.1016","volume":"158","author":[{"given":"Zheng","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie A.","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Winstanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Kraner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lundstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen R.","family":"Mock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2023.209252_bb0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/08897077.2021.1941505","article-title":"The impact of obesity in patients hospitalized with opioid\/opiate overdose","volume":"43","author":"Archibald","year":"2022","journal-title":"Substance Abuse"},{"issue":"7","key":"10.1016\/j.josat.2023.209252_bb0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/SAR.S108302","article-title":"Factors associated with opioid overdose: A 10-year retrospec- tive study of patients in a large integrated health care system","volume":"2016","author":"Boscarino","year":"2016","journal-title":"Substance Abuse and Rehabilitation"},{"key":"10.1016\/j.josat.2023.209252_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110352","article-title":"Quantifying enhanced risk from alcohol and other factors in polysubstance-related deaths","volume":"313","author":"Dai","year":"2020","journal-title":"Forensic Science International"},{"key":"10.1016\/j.josat.2023.209252_bb0020","series-title":"National drug threat assessment","author":"Drug Enforcement Administration (DEA)","year":"2019"},{"key":"10.1016\/j.josat.2023.209252_bb0025","author":"Duragesic (fentanyl transdermal system) Prescribing Information"},{"issue":"1\u20133","key":"10.1016\/j.josat.2023.209252_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.forsciint.2013.06.017","article-title":"Parenteral buprenorphine\u2013naloxone abuse is a major cause of fatal buprenorphine-related poisoning","volume":"232","author":"H\u00e4kkinen","year":"2013","journal-title":"Forensic Science International"},{"issue":"6","key":"10.1016\/j.josat.2023.209252_bb0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/biom11060816","article-title":"Buprenorphine: Far beyond the \u201cceiling\u201d","volume":"11","author":"Infantino","year":"2021","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.josat.2023.209252_bb0040","first-page":"523","article-title":"Accelerated overdose deaths linked with COVID-19","volume":"325","author":"Kuehn","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.josat.2023.209252_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2023.209252_bb0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.drugpo.2019.06.019","article-title":"\u201cThey\u2019re making it so hard for people to get help:\u201d Motivations for non-prescribed buprenorphine use in a time of treatment expansion","volume":"71","author":"McLean","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.josat.2023.209252_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256752","article-title":"Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volun- teers and opioid-tolerant patients","volume":"17","author":"Moss","year":"2022","journal-title":"PLoS One"},{"issue":"50","key":"10.1016\/j.josat.2023.209252_bb0060","first-page":"1740","article-title":"Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls\u2014United States, 2019\u20132020","volume":"70","author":"O\u2019Donnell","year":"2021","journal-title":"MMWR"},{"issue":"3","key":"10.1016\/j.josat.2023.209252_bb0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1309\/AJCP4X5VHFSOERFT","article-title":"Postmortem redistribution of fentanyl in blood","volume":"133","author":"Olson","year":"2010","journal-title":"American Journal of Clinical Pathology"},{"issue":"1","key":"10.1016\/j.josat.2023.209252_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amepre.2023.01.037","article-title":"Buprenorphine after nonfatal opioid overdose: Reduced mortality risk in Medicare disability beneficiaries","volume":"65","author":"Samples","year":"2023","journal-title":"American Journal of Preventive Medicine"},{"issue":"1\u20133","key":"10.1016\/j.josat.2023.209252_bb0075","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.forsciint.2012.03.016","article-title":"Toxicological and pathological findings in a series of buprenorphine related deaths. Possible risk factors for fatal outcome","volume":"220","author":"Seld\u00e9n","year":"2012","journal-title":"Forensic Science International"},{"key":"10.1016\/j.josat.2023.209252_bb0080","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00406-019-01091-0","article-title":"Buprenorphine\u2013cannabis interaction in patients undergoing opioid maintenance therapy","volume":"271","author":"Vierke","year":"2021","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"2","key":"10.1016\/j.josat.2023.209252_bb0085","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2023.209252_bb0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s13181-020-00795-3","article-title":"Opioid overdose deaths with buprenorphine detected in postmortem toxicology: A retrospective analysis","volume":"17","author":"Wightman","year":"2021","journal-title":"Journal of Medical Toxicology"},{"key":"10.1016\/j.josat.2023.209252_bb0095","series-title":"NAM perspectives. Commentary","article-title":"Dismantling buprenorphine policy can provide more comprehensive addiction treatment","author":"Woodruff","year":"2019"},{"key":"10.1016\/j.josat.2023.209252_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-2740-y","article-title":"Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: A prospective randomized trial","volume":"24","author":"Zamani","year":"2020","journal-title":"Critical Care"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923003041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923003041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:50:56Z","timestamp":1757433056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923003041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":20,"alternative-id":["S2949875923003041"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209252","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying a potential protective effect of buprenorphine on fatality risk during acute fentanyl exposures","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209252"}}